Health and Human Services Secretary Robert F. Kennedy Jr. announced Monday that the U.S. Food and Drug Administration would remove “broad black box” warnings from hormone replacement therapy products used to ease the symptoms of menopause.
More than 20 estrogen-related products used to treat hot flashes and other symptoms for decades will no longer carry a warning label about cardiovascular disease, breast cancer and probable dementia.